Form D · Venture Capital Fund
25M Health Ventures Fund I, L.P.
New York, NY · CIK 0001983411
Offering snapshot reported Jul 2, 2024 · SEC filing
- Reported sold
- $18M Offering amount: $35M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 6, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 14
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 2, 2024 | Amendment | $18,025,000 | No comparison | 14 | SEC filing |
| Jul 5, 2023 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-485943
The Total Amount Sold includes capital committed by the General Partner.
Source: Form D, filed Jul 2, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A 25 M Health Ventures Fund I Gp, Llc | Executive |
| Merrill Anovick | Executive |
| Fannie Chen | Executive |
| Steven Price | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
C/O 25 M Health Ventures 817 Broadway, Fl. 7
New York, NY, 10003
New York, NY, 10003